# Tailored Treatment in Metastatic Colorectal Cancer

> **NCT00396487** · PHASE3 · TERMINATED · sponsor: **Vejle Hospital** · enrollment: 1 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Capecitabine, Irinotecan, 5-Fluorouracil+Calciumfolinat

## Key facts

- **NCT ID:** NCT00396487
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Only one patient included as per Feb. 4, 2008.
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396487, "Tailored Treatment in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00396487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*